{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-019719","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.130480+00:00","generated_at":"2026-05-19T18:13:11.487375+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aytu BioPharma prices $14.4M upsized public offering of common stock and prefunded warrants","bullets":["Priced upsized public offering of 9,600,000 shares of common stock (or prefunded warrants) at $1.50 per share.","Granted underwriters 30-day option to purchase up to additional 1,440,000 shares of common stock.","Net proceeds of approximately $12.9M (or $14.9M if option exercised) to be used for general corporate purposes and to exclusively commercialize EXXUA (gepirone) for major depressive disorder.","Offering expected to close June 9, 2025; Lake Street Capital Markets acting as sole book runner.","Maxim Group LLC acting as lead manager and Ascendiant Capital Markets as financial advisor."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-019719","json":"https://secwatch.observer/filing/0001437749-25-019719.json","markdown":"https://secwatch.observer/filing/0001437749-25-019719.md","text":"https://secwatch.observer/filing/0001437749-25-019719.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925019719/0001437749-25-019719-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925019719/aytu20250605_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-19T18:13:11.487375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}